Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer 2017-05-10 05:03
Studies Further Validate Safety, Efficacy And An Improved Patient Experience In Use Of The C2 CryoBalloon(R) Ablation System For Primary Treatment Of Barrett's Esophagus 2017-05-09 20:00
New Real-World Analyses Support Effectiveness and Safety of Entyvio(R) (vedolizumab) for Ulcerative Colitis and Crohn's Disease 2017-05-08 23:08
CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET 2017-05-08 18:00
Norgine Presents New Post-hoc Data Analyses Highlighting the Efficacy of PLENVU® for Bowel Cleansing at DDW 2017-05-07 01:00
Sorrento Therapeutics Announces the Completion of GMP Manufacturing Plant in Suzhou, China to Support its Growing Antibody-Drug Conjugate (ADC) Pipeline and Service Business 2017-05-04 22:17
China Biologic Reports Financial Results for the First Quarter of 2017 2017-05-04 04:45
CARsgen Therapeutics Opens CAR T-cell Manufacturing Facility in Shanghai 2017-05-03 19:15
Stainwei Granted US Patent for anti-VEGF Monoclonal Antibody and its anti-PD-1 mAb demonstrating prolonged anti-tumor activity in pre-clinical studies 2017-05-03 18:00
Mederi Announces Stretta Presentation, Hands-On Training and New Data at DDW 2017 2017-05-02 19:11
Concord Medical Files 2016 Annual Report on Form 20-F 2017-05-02 17:00
Camurus and Braeburn Pharmaceuticals Announce Positive Top-line Results from Phase 3 Safety Study of CAM2038 2017-05-02 16:34
NeuroVive Invitation to Conference Call and Web Cast on in-licensing Agreement With Yungjin Pharm 2017-05-02 15:01
NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm 2017-05-02 11:51
Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors 2017-05-01 20:00
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics 2017-04-28 21:00
Britannia Pharmaceuticals: Landmark Apomorphine Study Confirms its Established Role as a Highly Effective Treatment for Parkinson's Disease Patients Whose Symptoms Cannot be Controlled on Standard Therapies 2017-04-26 05:51
Khaled El-Gendy Joins Pilatus Clinical Services Management Team 2017-04-25 09:00
China Biologic Products to Report First Quarter of 2017 Financial Results 2017-04-21 20:00
BioNet-Asia Organized International Pertussis Symposium Celebrating its 15th Anniversary in Bangkok 2017-04-21 17:57
1 375 376 377 378 379 412